None these patients had the clinical phenotype yet identified as a severe PAD phenotype, that is characterized by low IgG and IgA levels at diagnosis, IgA level <7 mg/dl, <2 % of switched memory B cells, presence of bronchiectasis, and/or enteropathy [15, 16, 22, 23]. This evidence concerns the gene CD79A and bronchiectasis.